Form 4: NeueHealth Insider Sandell Acquires Warrants Following Credit Agreement Amendment

Scott D. Sandell, a director of NeueHealth, indirectly acquired warrants to purchase common stock following an amendment to the company's credit agreement.

Summary

• Scott D. Sandell, a director at NeueHealth, filed a Form 4 disclosing the acquisition of warrants.
• The warrants are related to a Warrantholders Agreement dated April 8, 2024, and an amendment to the Credit Agreement.
• The warrants will be issued on the first business day following the conclusion of the 10 calendar day period after the distribution of the letter required to be mailed by the Issuer to its shareholders pursuant to Section 312.05 of the NYSE Listed Company Manual.
• The warrants are exercisable at any time after issuance and prior to the close of business on the fifth anniversary of the Closing Date.
• The warrants have an exercise price of $0.01.
• Sandell disclaims beneficial ownership of the securities held by NEA 15, NEA 16, NEA 17 and NEA 18 VGE in which the Reporting Person has no pecuniary interest.
• The total number of warrants acquired is 742,394.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to warrant acquisition, with no clear positive or negative implications.

Positives

• The acquisition of warrants by a director could be seen as a sign of confidence in the company's future prospects.

Future Outlook

The warrants will be exercisable at any time after issuance and prior to the close of business on the fifth anniversary of the Closing Date.

Industry Context

Insider transactions are closely watched by investors as they can provide insights into management's view of the company's prospects. Warrant issuances are a common financing tool.

Stakeholder Impact

• The issuance of warrants could potentially dilute existing shareholders if the warrants are exercised.

Next Steps

• Issuance of warrants following the 10-day period after the distribution of the letter required to be mailed by the Issuer to its shareholders pursuant to Section 312.05 of the NYSE Listed Company Manual.

Key Dates